Palomar's non-royalty revenues jump 300% in Q3

Palomar Medical touts great strides in sales during the 3rd quarter, with professional product revenues up 25% year-over-year and non-royalty sales up more than 300%.

Palomar Medical [1] (NSDQ:PMTI [2]) made big strides in its professional product revenues during the 3 months ended Sept. 30, 2012, but stayed in the red for the quarter.

The Burlington, Mass.-based aesthetic medical device maker reported a net loss of $4.7 million, or 25¢ per share, on sales of $18.5 million for the 3 months ended Sept. 30.

That compares with earnings $15.3 million, or 81¢ per share, on sales of $46.1 million during the same period last year, when the figures were bolstered by $31.6 million in royalty revenues stemming from a lawsuit [3] against Syneron Medical Ltd. [4] (NSDQ:ELOS [5]).